Incidence and prognosis of carcinoid syndrome: hormones or tumour burden? – Authors' reply

Daniel M. Halperin, Chan Shen, James C. Yao

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)e300
JournalThe Lancet Oncology
Volume18
Issue number6
DOIs
StatePublished - Jun 1 2017

Fingerprint

Carcinoid Tumor
Tumor Burden
Hormones
Incidence

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

@article{302b46f7ac584f26b1b15d414014e837,
title = "Incidence and prognosis of carcinoid syndrome: hormones or tumour burden? – Authors' reply",
author = "Halperin, {Daniel M.} and Chan Shen and Yao, {James C.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/S1470-2045(17)30347-9",
language = "English (US)",
volume = "18",
pages = "e300",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "6",

}

Incidence and prognosis of carcinoid syndrome : hormones or tumour burden? – Authors' reply. / Halperin, Daniel M.; Shen, Chan; Yao, James C.

In: The Lancet Oncology, Vol. 18, No. 6, 01.06.2017, p. e300.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Incidence and prognosis of carcinoid syndrome

T2 - hormones or tumour burden? – Authors' reply

AU - Halperin, Daniel M.

AU - Shen, Chan

AU - Yao, James C.

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85020891547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020891547&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(17)30347-9

DO - 10.1016/S1470-2045(17)30347-9

M3 - Letter

C2 - 28593855

AN - SCOPUS:85020891547

VL - 18

SP - e300

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 6

ER -